These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28827754)

  • 41. Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial.
    Launay O; Rosenberg AR; Rey D; Pouget N; Michel ML; Reynes J; Neau D; Raffi F; Piroth L; Carrat F;
    JAMA Intern Med; 2016 May; 176(5):603-10. PubMed ID: 27064975
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis B infection awareness, vaccine perceptions and uptake, and serological profile of a group of health care workers in Yaoundé, Cameroon.
    Tatsilong HO; Noubiap JJ; Nansseu JR; Aminde LN; Bigna JJ; Ndze VN; Moyou RS
    BMC Public Health; 2016 Aug; 15():706. PubMed ID: 27487845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered Memory Circulating T Follicular Helper-B Cell Interaction in Early Acute HIV Infection.
    Muir R; Metcalf T; Tardif V; Takata H; Phanuphak N; Kroon E; Colby DJ; Trichavaroj R; Valcour V; Robb ML; Michael NL; Ananworanich J; Trautmann L; Haddad EK;
    PLoS Pathog; 2016 Jul; 12(7):e1005777. PubMed ID: 27463374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients.
    Cruciani M; Mengoli C; Serpelloni G; Lanza A; Gomma M; Nardi S; Rimondo C; Bricolo F; Consolaro S; Trevisan M; Bosco O
    Vaccine; 2009 Jan; 27(1):17-22. PubMed ID: 18984022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid loss of vaccine-acquired hepatitis B surface antibody after three doses of hepatitis B vaccination in HIV-infected persons.
    Mizusawa M; Perlman DC; Lucido D; Salomon N
    Int J STD AIDS; 2014 Mar; 25(3):201-6. PubMed ID: 24216032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors for predicting successful immune response to hepatitis B vaccination in HIV-1 infected patients.
    Ungulkraiwit P; Jongjirawisan Y; Atamasirikul K; Sungkanuparph S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):680-5. PubMed ID: 17883006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
    Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K
    J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Escalated regimen of hepatitis B vaccine in childhood hematological malignancies while on chemotherapy.
    Ghosh N; Mannan MA; Monjur F; Rizwan F; Salim AF
    Southeast Asian J Trop Med Public Health; 2010 May; 41(3):555-61. PubMed ID: 20578542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
    Halota W; Muszyńska M; Pawłowska M
    Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy.
    Paitoonpong L; Suankratay C
    Scand J Infect Dis; 2008; 40(1):54-8. PubMed ID: 17852939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A High Frequency of HIV-Specific Circulating Follicular Helper T Cells Is Associated with Preserved Memory B Cell Responses in HIV Controllers.
    Claireaux M; Galperin M; Benati D; Nouël A; Mukhopadhyay M; Klingler J; de Truchis P; Zucman D; Hendou S; Boufassa F; Moog C; Lambotte O; Chakrabarti LA
    mBio; 2018 May; 9(3):. PubMed ID: 29739909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
    Launay O; van der Vliet D; Rosenberg AR; Michel ML; Piroth L; Rey D; Colin de Verdière N; Slama L; Martin K; Lortholary O; Carrat F;
    JAMA; 2011 Apr; 305(14):1432-40. PubMed ID: 21486976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya.
    Irungu E; Mugo N; Ngure K; Njuguna R; Celum C; Farquhar C; Dhanireddy S; Baeten JM
    J Infect Dis; 2013 Feb; 207(3):402-10. PubMed ID: 23175769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
    He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
    Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigen-specific T cell response in infants after recombinant hepatitis B virus vaccination at birth: evaluation of T helper lymphocyte diversity.
    Avanzini MA; Belloni C; De Silvestri A; Castellazzi AM; Marconi M; Moretta A; Montagna D; Martinetti M; Cuccia M; Rondini G; Ciardelli L; Maccario R
    Clin Immunol; 2003 May; 107(2):122-8. PubMed ID: 12763481
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection.
    Shive CL; Judge CJ; Clagett B; Kalayjian RC; Osborn M; Sherman KE; Fichtenbaum C; Gandhi RT; Kang M; Popkin DL; Sieg SF; Lederman MM; Rodriguez B; Anthony DD
    Vaccine; 2018 Jan; 36(4):453-460. PubMed ID: 29254840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between hepatitis B vaccine antibody response and CD4 reconstitution after initiation of combination antiretroviral therapy in HIV-infected persons.
    Allen K; Mesner O; Ganesan A; O'Bryan TA; Deiss RG; Agan BK; Okulicz JF
    BMC Infect Dis; 2015 May; 15():203. PubMed ID: 25928043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A double-dose hepatitis B vaccination schedule in travelers presenting for late consultation.
    Wong J; Payne M; Hollenberg S
    J Travel Med; 2014; 21(4):260-5. PubMed ID: 24796543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.